Ivermectin is a medication that has gained significant public attention over the years, leading many people to ask important questions about what it actually does and whether it may have a role beyond its original purpose, including in cancer care.
This article explains what ivermectin is, what it’s used for, how it works in the body, and what current research says about ivermectin. 
What Is Ivermectin?
Ivermectin is a prescription medication that has been safely used in humans for decades. It is classified as an antiparasitic drug and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific parasitic infections.
FDA-Approved Uses in Humans Include:
- Strongyloidiasis (intestinal roundworm infection)
- Onchocerciasis (river blindness)
- Scabies and lice (in certain formulations)
When used at approved doses and for approved conditions, ivermectin has a long record of safety and effectiveness.
How Does Ivermectin Work?
Ivermectin works by interfering with the nervous system of parasites, leading to paralysis and death of the organism. It targets specific ion channels that are present in parasites but not found in the same way in humans, which is why it can be effective without harming human cells when used correctly.
Beyond its antiparasitic action, laboratory research has shown ivermectin can influence:
- Cellular signaling pathways
- Inflammation processes
- Immune system responses
These additional biological effects are what sparked scientific interest in ivermectin’s potential role in other diseases including cancer at a research level.
Ivermectin and Cancer
Laboratory and Animal Studies (Preclinical Research)
In preclinical studies (test-tube and animal models), ivermectin has demonstrated several properties that researchers find interesting:
- Inhibition of cancer cell growth
- Induction of apoptosis (programmed cancer cell death)
- Reduction in tumor cell migration and spread
- Possible enhancement of chemotherapy sensitivity in resistant cancer cells
- Immune system modulation within the tumor microenvironment
These findings suggest ivermectin may affect biological pathways involved in cancer development and progression.
Evidence-Based Care Comes First
At Apple A Day Virtual Clinic, we believe in empowering patients with accurate, science-backed information. If you’re exploring treatment options, managing a diagnosis, or simply want clarity on medications you’ve heard about, our providers are here to help guide you safely and responsibly.
Reach out today to speak with a licensed clinician and get personalized, evidence-based care.
Sources: